Regulatory source record
FDA & DEA Kratom Timeline: 7-OH Actions
Federal actions differ by compound and product. A warning, a proposed threshold, and an effective scheduling order have different consequences; the dated source controls.
By Kratom Finder Editorial · Updated . Source-based editorial update; no new clinician review is claimed.
August 26, 2026: three related compounds scheduled
DEA issued a temporary Schedule I order for mitragynine pseudoindoxyl, MGM-15, and MGM-16. The order identifies the covered substances and takes effect August 26, 2026. It is distinct from the separate proceeding about a threshold for 7-OH.
August 26, 2026: 7-OH threshold comments extended
HHS extended the comment period on the proposed 7-OH threshold. An extension or a notice of intent is not itself a final scheduling order. Check the applicable Federal Register proceeding for subsequent orders and effective dates.
July 1, 2026: DEA announces intent to schedule
DEA announced two notices: one concerning 7-OH above a specified threshold and another covering three related substances. The announcement explains that controls take effect through scheduling orders, not simply through the announcement.
December 2, 2025: seizure of 7-OH products
FDA announced that the U.S. Marshals Service seized approximately 73,000 units of 7-OH products from three Missouri firms, in coordination with the Department of Justice. This is a specific enforcement event, not a statement about every product sold as kratom.
July 29, 2025: FDA recommends scheduling action
FDA recommended controlling certain 7-OH products and described the next steps involving DEA. The announcement focused on concentrated 7-OH products. That scope does not establish that leaf products meet federal requirements for foods, supplements, or medical claims.
July 15, 2025: warning-letter announcement
FDA announced warning letters to seven firms marketing products containing 7-OH. A warning letter identifies the agency’s stated violations; it is not product approval or a clinical comparison between brands.
How to use this timeline
This is a selected chronology of verified agency documents, checked September 8, 2026. Each source must be read for its scope. State and local requirements are separate, and later regulatory changes may supersede an earlier notice.
Sources
- Federal Register: August 26, 2026 temporary order for three related compounds
- Federal Register: August 26, 2026 extension of comments on the 7-OH threshold
- DEA: July 1, 2026 notices of intent
- FDA: December 2, 2025 seizure announcement
- FDA: July 29, 2025 scheduling recommendation
- FDA: July 15, 2025 warning-letter announcement
Sources support the stated facts; they do not validate an individual product or replace personal medical care. Report a correction.
Related information
Safety overview · All articles · State rules · Store directory